CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase ; volume:103 ; number:11 ; day:21 ; month:9 ; year:2024 ; pages:4811-4815 ; date:11.2024
Annals of hematology ; 103, Heft 11 (21.9.2024), 4811-4815, 11.2024

Creator: Kramp, Laura-Jane
Heydrich-Karsten, Christiane
Sembill, Stephanie
Karow, Axel
Lion, Thomas
Chitadze, Guranda
Suttorp, Meinolf
Cario, Gunnar
Metzler, Markus

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00277-024-06011-4

URN: urn:nbn:de:101:1-2501222116063.674016611764

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kramp, Laura-Jane
Heydrich-Karsten, Christiane
Sembill, Stephanie
Karow, Axel
Lion, Thomas
Chitadze, Guranda
Suttorp, Meinolf
Cario, Gunnar
Metzler, Markus
SpringerLink (Online service)

Other Objects (12)

Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia

Hochschulschrift

Lymphoid specific gene rearrangement and mutation mechanisms in chronic myeloid leukemia blast crisis

Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis

$Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy$

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

Treatment of Relapsed Acute Myeloid Leukemia

$First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia$

First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia

$Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values$

Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values

$Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond$

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

Relapsed acute myeloid leukemia presenting as conjunctival myeloid sarcoma: a case report

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia

Blast - T cell - interaction in pediatric acute myeloid leukemia

Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia

Hochschulschrift

Lymphoid specific gene rearrangement and mutation mechanisms in chronic myeloid leukemia blast crisis

Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis

$Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy$

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

Treatment of Relapsed Acute Myeloid Leukemia

$First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia$

First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia

$Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values$

Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values

$Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond$

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

Relapsed acute myeloid leukemia presenting as conjunctival myeloid sarcoma: a case report

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia

Blast - T cell - interaction in pediatric acute myeloid leukemia

Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia

Hochschulschrift

Lymphoid specific gene rearrangement and mutation mechanisms in chronic myeloid leukemia blast crisis

Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis

$Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy$

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

Treatment of Relapsed Acute Myeloid Leukemia

$First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia$

First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia

$Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values$

Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values

$Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond$

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

Relapsed acute myeloid leukemia presenting as conjunctival myeloid sarcoma: a case report

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia

Blast - T cell - interaction in pediatric acute myeloid leukemia

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia

Lymphoid specific gene rearrangement and mutation mechanisms in chronic myeloid leukemia blast crisis

Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

Treatment of Relapsed Acute Myeloid Leukemia

First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia

Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

Relapsed acute myeloid leukemia presenting as conjunctival myeloid sarcoma: a case report

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia

Blast - T cell - interaction in pediatric acute myeloid leukemia

Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia

Lymphoid specific gene rearrangement and mutation mechanisms in chronic myeloid leukemia blast crisis

Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

Treatment of Relapsed Acute Myeloid Leukemia

First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia

Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

Relapsed acute myeloid leukemia presenting as conjunctival myeloid sarcoma: a case report

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia

Blast - T cell - interaction in pediatric acute myeloid leukemia

Bilateral Serous Retinal Detachment in Lymphoid Blast Crisis of Chronic Myeloid Leukemia

Lymphoid specific gene rearrangement and mutation mechanisms in chronic myeloid leukemia blast crisis

Chronic myeloid leukemia with an e1a3 BCR-ABL fusion protein: transformation to lymphoid blast crisis

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

Treatment of Relapsed Acute Myeloid Leukemia

First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia

Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

Relapsed acute myeloid leukemia presenting as conjunctival myeloid sarcoma: a case report

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Deletions of Immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia

Blast - T cell - interaction in pediatric acute myeloid leukemia

Related objects

Reset password